logo
Select company
Select metric
$ -0.6EBITDA per Share
VS
Market
22
Sector
55
Industry
72
History
93
$ 0.46Close
$ 0.41 - $ 3.18 52-Week Range
Ticker Information

Ticker

RANI

Company Name

RANI THERAPEUTICS HOLDINGS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

RANI THERAPEUTICS HOLDINGS INC - EBITDA per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

RANI - EBITDAPS Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA per ShareShare FactorWeighted Average Shares
6/30/2025$ -22.1M$ -0.6136.54M
3/31/2025$ -22.18M$ -0.66133.44M
12/31/2024$ -22.15M$ -0.78128.48M
9/30/2024$ -20.38M$ -0.71128.84M
6/30/2024$ -23.45M$ -0.89126.32M
3/31/2024$ -25.87M$ -0.99126.03M
12/31/2023$ -27.02M$ -1.06125.5M
9/30/2023$ -29.41M$ -1.15125.55M
6/30/2023$ -29.36M$ -1.16125.34M
3/31/2023$ -37.3M$ -1.48125.24M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • RANI THERAPEUTICS HOLDINGS INC's latest trailing twelve months (TTM) EBITDAPS stands at $ -0.34.
  • Over the past 5 years, RANI THERAPEUTICS HOLDINGS INC's average EBITDAPS has been $ -1.34.
  • The median EBITDAPS for RANI THERAPEUTICS HOLDINGS INC during this period was $ -1.11
  • RANI THERAPEUTICS HOLDINGS INC reached its highest EBITDAPS over the past 5 years at $ -0.34.
  • The lowest EBITDAPS recorded by RANI THERAPEUTICS HOLDINGS INC in the same timeframe $ -2.9

RANI THERAPEUTICS HOLDINGS INC's EBITDAPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDAPS Benchmarks
CompanyEBITDAPS
PLUR : PLURI INC $ -3.34IGC : IGC PHARMA INC $ -0.07CLSD : CLEARSIDE BIOMEDICAL INC $ -5.14DTIL : PRECISION BIOSCIENCES INC $ -6.67LSTA : LISATA THERAPEUTICS INC $ -2.29SONN : SONNET BIOTHERAPEUTICS HOLDINGS INC $ -3.36ADVM : ADVERUM BIOTECHNOLOGIES INC $ -7.63RNXT : RENOVORX INC $ -0.3RLYB : RALLYBIO CORP $ -0.93CLNN : CLENE INC $ -2.6

Similar metrics to Shares WA:

Definition of EBITDA per Share

[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS EBITDAPS for RANI THERAPEUTICS HOLDINGS INC is calculated as follows: EBITDA [ $ -15.96M ] / (Shares WA [ 46.89M ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -0.34 ]

RANI - EBITDA per Share, Last 5 years

$ -2.9

Minimum

Jun 30, 2022

$ -0.34

Maximum

Dec 31, 2020

$ -1.34

Average

$ -1.11

Median

EBITDAPS Benchmark Analysis

 The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.03 with a standard deviation of $ 4.28.
The following table provides additional summary stats:
EBITDAPS in the Market:
filtered constituents3.78K
min$ -11.29
max$ 14.03
average$ 2.03
median$ 1
std$ 4.28